Taiwan FDA granted the API Market License of Pemetrexed Disodium Hemipentahydrate "GBC"
Taiwan FDA granted the in-house developed Generic Oncology (Cytotoxic) Active Pharmaceutical Ingredient Market License of Pemetrexed Disodium Hemipentahydrate, Registration Number: MOHW-PM060543 (DMF No. : DMF(00)3416)
